BACKGROUND Before the advent of fibrinolytic therapy as a gold standard method of care for cases of acute ischemic stroke in Romania, issues regarding legal medicine aspects involved in this area of medical expertise were already presented and, in the majority of cases, the doctors seem to be unprepared for these situations. MAIN TEXT The present research illustrates some of the cases in which these aspects were involved, that adressed a clinical center having 6 years of professional experience in the application of fibrinolytic treatment for stroke. The following cases report either situations in which the afore mentioned therapy was not rightfully administrated or legal aspects regarding the obtainment of informed consent. CONCLUSION Obtaining informed consent is a mandatory procedure, which takes time, to the detriment of application of fibrinolytic treatment.

中文翻译：

---

法律医学对急性缺血性卒中的纤溶治疗的意义。

背景技术在纤溶酶疗法作为罗马尼亚急性缺血性中风病例的金标准护理方法出现之前，已经提出了涉及该医学专业知识领域的法律医学方面的问题，并且在大多数情况下，医生似乎为这些情况做好准备。主要研究内容本研究说明了涉及这些方面的一些案例，该案例涉及一个在纤溶治疗中风方面有6年专业经验的临床中心。以下案例报告了上述疗法未得到正确管理的情况，或有关获得知情同意的法律方面的报道。结论获得知情同意是一项强制性程序，需要时间，